Trust Co. of Vermont Acquires 410 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Trust Co. of Vermont grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.8% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,049 shares of the medical equipment provider’s stock after acquiring an additional 410 shares during the quarter. Trust Co. of Vermont’s holdings in Intuitive Surgical were worth $2,246,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Baystate Wealth Management LLC raised its stake in Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 45 shares in the last quarter. Creekmur Asset Management LLC increased its stake in shares of Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 42 shares during the period. MCF Advisors LLC boosted its holdings in Intuitive Surgical by 108.1% in the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after acquiring an additional 40 shares during the last quarter. Able Wealth Management LLC bought a new stake in Intuitive Surgical in the fourth quarter valued at approximately $28,000. Finally, Delos Wealth Advisors LLC boosted its holdings in Intuitive Surgical by 380.0% in the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 57 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, EVP Robert Desantis sold 239 shares of the stock in a transaction on Friday, May 10th. The stock was sold at an average price of $385.55, for a total value of $92,146.45. Following the completion of the sale, the executive vice president now directly owns 5,507 shares of the company’s stock, valued at approximately $2,123,223.85. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total transaction of $641,382.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Desantis sold 239 shares of the firm’s stock in a transaction on Friday, May 10th. The shares were sold at an average price of $385.55, for a total value of $92,146.45. Following the sale, the executive vice president now directly owns 5,507 shares of the company’s stock, valued at $2,123,223.85. The disclosure for this sale can be found here. In the last three months, insiders sold 16,005 shares of company stock valued at $6,894,422. 0.90% of the stock is owned by insiders.

Analysts Set New Price Targets

ISRG has been the topic of several analyst reports. Barclays upped their target price on Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a report on Thursday, July 18th. Jefferies Financial Group upped their target price on Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a report on Friday, April 19th. Citigroup upped their target price on Intuitive Surgical from $462.00 to $512.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. JPMorgan Chase & Co. upped their target price on Intuitive Surgical from $475.00 to $495.00 and gave the company an “overweight” rating in a report on Friday, July 19th. Finally, Stifel Nicolaus upped their target price on Intuitive Surgical from $430.00 to $475.00 and gave the company a “buy” rating in a report on Friday, July 19th. Six investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $442.30.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG traded up $9.66 during trading on Tuesday, reaching $447.66. 1,662,729 shares of the stock were exchanged, compared to its average volume of 1,573,488. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $468.78. The stock has a fifty day moving average of $432.79 and a two-hundred day moving average of $402.15. The firm has a market cap of $158.79 billion, a price-to-earnings ratio of 80.81, a price-to-earnings-growth ratio of 4.97 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. The business had revenue of $2.01 billion during the quarter, compared to analyst estimates of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. Intuitive Surgical’s quarterly revenue was up 14.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.18 EPS. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.